PMC:7228307 / 48998-49159 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"976","span":{"begin":62,"end":70},"obj":"Gene"},{"id":"977","span":{"begin":42,"end":48},"obj":"Chemical"}],"attributes":[{"id":"A976","pred":"tao:has_database_id","subj":"976","obj":"Gene:2214"},{"id":"A977","pred":"tao:has_database_id","subj":"977","obj":"MESH:D011134"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Thus, the engineering of the Fc domain or glycan for improved FcγRIIIa binding is a powerful tool to create more potent and clinically effective anticancer mAbs."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T838","span":{"begin":29,"end":31},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T839","span":{"begin":62,"end":64},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T840","span":{"begin":82,"end":83},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Thus, the engineering of the Fc domain or glycan for improved FcγRIIIa binding is a powerful tool to create more potent and clinically effective anticancer mAbs."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"976","span":{"begin":62,"end":70},"obj":"Gene"},{"id":"977","span":{"begin":42,"end":48},"obj":"Chemical"}],"attributes":[{"id":"A976","pred":"pubann:denotes","subj":"976","obj":"Gene:2214"},{"id":"A977","pred":"pubann:denotes","subj":"977","obj":"MESH:D011134"}],"text":"Thus, the engineering of the Fc domain or glycan for improved FcγRIIIa binding is a powerful tool to create more potent and clinically effective anticancer mAbs."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T281","span":{"begin":0,"end":161},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Thus, the engineering of the Fc domain or glycan for improved FcγRIIIa binding is a powerful tool to create more potent and clinically effective anticancer mAbs."}

{"project":"LitCovid-sentences","denotations":[{"id":"T281","span":{"begin":0,"end":161},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Thus, the engineering of the Fc domain or glycan for improved FcγRIIIa binding is a powerful tool to create more potent and clinically effective anticancer mAbs."}